title: Cardiac K+ channels and drug-acquired long QT syndrome.
abstract: The hallmark of long QT syndromes (LQTS) is an abnormal ventricular repolarization characterized by a prolonged QT interval on the electrocardiogram and a propensity to the occurrence of syncopes resulting from polymorphic ventricular tachycardia, called torsades de pointes. They may degenerate to ventricular fibrillation, possibly causing sudden death. Congenital LQTS, which implicates at least six chromosomal loci, LQT1 to LQT6, three of them corresponding to mutations concerning the coding of K+ channel proteins, give useful information about the mechanism underlying the arrhythmia. One of the potassium channel genes implicated in congenital LQTS is HERG, which encodes the IKr current channel protein. This current has provided a relevant insight into the occurrence of drug-acquired LQTS, since all drugs associated with torsades, such as erythromycin, terfenadine, haloperidol, or cisapride, also block IKr.
authors.affiliation: CNRS-UPR 411, Valbonne-France.
authors.forename: M D
authors.initials: MD
authors.lastname: Drici
authors.forename: J
authors.initials: J
authors.lastname: Barhanin
mesh_terms: D006321:Heart / Q000503:physiopathology*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D015221:Potassium Channels / Q000235:genetics / Q000502:physiology*
chemical_list: D015221:Potassium Channels